Bevacizumab (Avastin) for the treatment of ocular disease.
PubMed ID: 19422965 Author(s): Gunther JB, Altaweel MM. Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol. 2009 May-Jun;54(3):372-400. doi: 10.1016/j.survophthal.2009.02.004. Review. PMID 19422965 Journal: Survey Of Ophthalmology, Volume 54, Issue 3, 2009 The use of intravitreal bevacizumab (Avastin) has greatly expanded since its introduction into ophthalmic care 3 years ago. A PubMed search …